Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Biochemistry
|
March 4, 1998
Ultratight DNA binding of a new bisintercalating anthracycline antibiotic
F Leng, W Priebe, J B Chaires
The Journal of Antibiotics
|
March 1, 1992
3'-Hydroxyesorubicin halogenated at C-2'
W Priebe, N Neamati, R Perez-soler
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size
Y Zou, W Priebe, R Perez-Soler
Carbohydrate Research
|
July 16, 1981
Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone
D Horton, W Priebe, W R Turner
Nucleic Acids Research
|
August 14, 1999
Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro
B Martín, A Vaquero, W Priebe, et al.
Biochemical Pharmacology
|
October 6, 2000
Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes
C Marbeuf-Gueye, W Priebe, A Garnier-Suillerot
European Journal of Biochemistry
|
September 1, 1996
Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity
Y G Gao, W Priebe, A H Wang
Cancer Research
|
April 15, 1993
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells
Y H Ling, W Priebe, R Perez-Soler
Journal of Pharmaceutical Sciences
|
November 1, 1993
Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography
Y Zou, A Hayman, W Priebe, et al.
Biochemical Pharmacology
|
October 5, 2001
The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin
C Loetchutinat, C Heywang, W Priebe, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Biochemistry
|
March 4, 1998
Ultratight DNA binding of a new bisintercalating anthracycline antibiotic
F Leng, W Priebe, J B Chaires
The Journal of Antibiotics
|
March 1, 1992
3'-Hydroxyesorubicin halogenated at C-2'
W Priebe, N Neamati, R Perez-soler
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size
Y Zou, W Priebe, R Perez-Soler
Carbohydrate Research
|
July 16, 1981
Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone
D Horton, W Priebe, W R Turner
Nucleic Acids Research
|
August 14, 1999
Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro
B Martín, A Vaquero, W Priebe, et al.
Biochemical Pharmacology
|
October 6, 2000
Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes
C Marbeuf-Gueye, W Priebe, A Garnier-Suillerot
European Journal of Biochemistry
|
September 1, 1996
Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity
Y G Gao, W Priebe, A H Wang
Cancer Research
|
April 15, 1993
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells
Y H Ling, W Priebe, R Perez-Soler
Journal of Pharmaceutical Sciences
|
November 1, 1993
Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography
Y Zou, A Hayman, W Priebe, et al.
Biochemical Pharmacology
|
October 5, 2001
The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin
C Loetchutinat, C Heywang, W Priebe, et al.
Page
of 9